Givaudan | GIVN - Sales Revenues

Stock Price
3,095.00
Daily Change
12.00 0.39%
Monthly
-0.80%
Yearly
-19.61%
Q1 Forecast
2,915.39

Givaudan reported CHF1.87B in Sales Revenues for its fiscal semester ending in June of 2024.





Sales Change Date
Air Liquide EUR 6.6B 430M Jun/2025
Akzo Nobel EUR 2.37B 180M Dec/2025
Anheuser-Busch USD 15.13B 130M Sep/2025
Arkema EUR 2.19B 210M Sep/2025
Associated British Foods GBP 9.95B 441M Sep/2025
BASF EUR 14.33B 1.44B Sep/2025
Bayer EUR 9.66B 1.08B Sep/2025
Beiersdorf EUR 2.35B 150M Sep/2025
British American Tobacco GBP 12.07B 1.46B Jun/2025
Covestro EUR 3.17B 210M Sep/2025
Croda International GBP 413.5M 398.7M Jun/2025
Danone EUR 6.88B 6.74B Jun/2025
Diageo GBP 9.35B 1.55B Jun/2025
Fresenius EUR 5.48B 100M Sep/2025
Fresenius Medical Care EUR 4.89B 100M Sep/2025
Givaudan CHF 1.87B 1.51B Jun/2024
Glanbia EUR 2.02B 208.5M Jan/2025
Heineken EUR 14.18B 969M Jun/2025
Henkel EUR 5.16B 5.61B Jun/2025
International Flavors Fragrances USD 2.69B 70M Sep/2025
Johnson Matthey GBP 1.28B 4.76B Sep/2025
Kerry EUR 3.88B 0 Dec/2024
Lonza CHF 3.58B 63M Jun/2025
L'Oréal EUR 10.74B 990M Jun/2025
Merck EUR 5.32B 890M Sep/2025
Nestle CHF 44.23B 2.08B Jun/2025
Pernod Ricard EUR 2.38B 100M Jun/2025
Reckitt Benckiser GBP 3.3B 3.7B Jun/2025
SGS CHF 3.46B 1.79B Dec/2024
Sika AG CHF 5.68B 251.9M Jun/2025
Solvay EUR 1.04B 60M Sep/2025
Tate & Lyle GBP 1.02B 0 Dec/2025
Umicore EUR 1.79B 130M Jun/2025
Victrex GBP 75.5M 70.4M Sep/2025